carcik-cd19
Cell therapyexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Dec 20, 2017 (NCT03389035)
Timeline
Indications
Mechanism of action
- B-lymphocyte antigen CD19Immunity, passive
CD19 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05869279 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2023 | Fondazione Matilde Tettamanti Menotti De Marchi Onlus |
| NCT05252403 | Phase 2 | Dec 1, 2021 | Fondazione Matilde Tettamanti Menotti De Marchi Onlus |
| NCT03389035 | Phase 1/Phase 2 (Phase 2) | Dec 20, 2017 | Fondazione Matilde Tettamanti Menotti De Marchi Onlus |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fondazione Matilde Tettamanti Menotti De Marchi Onlus | Academic/Hospital | 3 | 3 | 1 | 2017 |
1 organizations
Page 1 / 1